Paper Review Records
全部论文审稿周期
24 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
161
天
Effect of dolutegravir on ‘Life's Simple 7’ cardiovascular risk factors: A longitudinal analysis from Tanzania
作者
Gloria J. Manyangu; Bahati Wajanga; Bernard Desderius; Salama Fadhili; Megan Willkens; Christina Myalla; Godfrey A. Kisigo; George Praygod; Myung H. Lee; Robert N. Peck; Samuel Kalluvya; Lily D. Yan展开收起
作者单位
1. Department of Community Health Bugando Medical Centre Mwanza United Republic of Tanzania; 2. School of Public Health, Catholic University of Health and Allied Sciences Mwanza United Republic of Tanzania; 3. Department of Internal Medicine Bugando Medical Centre Mwanza United Republic of Tanzania; 4. Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences Mwanza United Republic of Tanzania; 5. National Institute for Medical Research, Mwanza Intervention Trials Unit Mwanza United Republic of Tanzania; 6. Center of Global Health, Weill Cornell Medicine New York New York USA; 7. National Institute for Medical Research Dar es Salaam United Republic of Tanzania; 8. Research and Consultancy Unit Bugando Medical Centre Mwanza United Republic of Tanzania展开收起
57
天
Prior PrEP use and discontinuation in individuals newly diagnosed with HIV
作者
Rohan Saini; Sarah Fidler; Marta Boffito; Vicky Tittle; Nicolo Girometti; Gary Whitlock; the Dean Street Collaborative Group展开收起
作者单位
1. Imperial College London London UK; 2. Chelsea and Westminster Hospital London UK展开收起
76
天
Models of care for women living with HIV in Europe: A scoping review
作者
D. Rao; O. M. Inescu; C. A. Sabin; O. Sǎndulescu; G. Dragovic; Å. Mellgren; J. Kowalska; G. Lourida; E. Moseholm; EACS WAVE Health Care Perception Working Group展开收起
作者单位
1. Institute of International Health Charité‐Universitätsmedizin Berlin Berlin Germany; 2. Department of Infectious Diseases I, Faculty of Medicine Carol Davila University of Medicine and Pharmacy Bucharest Romania; 3. National Institute for Infectious Diseases “Prof. Dr. Matei Bals” Bucharest Romania; 4. Department of Infection and Population Health, Institute for Global Health University College London London UK; 5. Society for Research and Innovation in Infectious Diseases Bucharest Romania; 6. Faculty of Medicine University of Belgrade, Institute of Pharmacology, Clinical Pharmacology and Toxicology Belgrade Serbia; 7. Department of Biomedicine, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden; 8. Clinic of Infectious Diseases, Region Västra Götaland Sahlgrenska University Hospital Gothenburg Sweden; 9. Infectious Diseases Observational Research Unit Medical University of Warsaw Warsaw Poland; 10. ID/HIV Department Evangelismos General Hospital Athens Greece; 11. Department of Infectious Diseases Copenhagen University Hospital Hvidovre Denmark; 12. Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark展开收起
60
天
Legal status, sex work engagement and inequities in the HIV pre‐exposure prophylaxis cascade among migrant women in 11 European countries
作者
Haoyi Wang; Anne Flaherty‐Gupta; Hala Majdoub; Edwin Sesange; Kim Isip; Justine Lubnow; Pedro Barrios Sanchez; Linda Pavanello; Etinosa Erevbenagie‐Johnbull; Lillian Petry; Emma Gooding; Magdalena Ankiersztejn‐Bartczak; Stavroula Triantafyllidou; Ann Piercy; Kai J. Jonas; Denis Onyango; Hanne M. L. Zimmermann; the MiHealth HIV Partnership展开收起
作者单位
1. Department of Work and Social Psychology Maastricht University Maastricht the Netherlands; 2. Africa Advocacy Foundation London UK; 3. Association PASTT Paris France; 4. Blue Door Education Valletta Malta; 5. Asociacion Karibu Madrid Spain; 6. Comitato per I Diritti Civili delle Prostitute APS Trieste Italy; 7. Generation for Change CY Nicosla Cyprus; 8. GHSAG‐Gh Support Association Germany e.V Saarbrücken Germany; 9. Oasis Belgium Ixelles Belgium; 10. Foundation for Social Education Warsaw Poland; 11. Positive Voice Athens Greece; 12. HIV Ireland Dublin Ireland展开收起
100
天
Hodgkin and non‐Hodgkin lymphomas in the post‐antiretroviral therapy era according to HIV virological suppression
作者
Teresa Aldámiz‐Echevarria; Francisco Tejerina; Chiara Fanciulli; Cristina Diez; Leire Perez; José Maria Bellón; Nuria Espinosa; Santiago Moreno Guillén; Maria del Mar Arcos‐Rueda; Marta Montero‐Alonso; Lucio García‐Fraile; Victor Asensi; Marian Fernández López; Diana Corona‐Mata; Alfonso Cabello‐Úbeda; Meritxell Gavaldà Manso; Jose Antonio Iribarren; Laura Pérez‐Martínez; María Remedios Alemán Valls; Irene Portilla‐Tamarit; Joaquim Peraire; Inés Suárez‐García; Mar Masiá; María José Núñez Orantos; Ángela Gutiérrez Liarte; Arkaitz Imaz; Cristina Hernández Gutiérrez; Maria Tasias Pitarch; Marta Rava; CoRIS Cohort展开收起
作者单位
1. Servicio de Microbiología Clínica y Enfermedades Infecciosas Gregorio Marañón General University Hospital Madrid Spain; 2. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) Madrid Spain; 3. CIBERINFEC, ISCIII – CIBER de Enfermedades Infecciosas Instituto de Salud Carlos III Madrid Spain; 4. Unidad clínica de Enfermedades Infecciosas, microbiología y parasitologías (UCEIMP) Hospital Universitario Virgen del Roci) Sevilla Spain; 5. Head Department of Infectious Diseases Jefe de Servicio de Enfermedades Infecciosas Madrid Spain; 6. Medicine Hospital Universitario Ramón y Cajal University Hospital Ramón y Cajal Universidad de Alcalá/Alcalá University Madrid Spain; 7. HIV Unit. Internal Medicine Department Hospital Universitario La Paz‐Carlos III, IdiPAZ Madrid Spain; 8. Unidad de Enfermedades Infecciosas Hospital Universitario y Politécnico La Fe Instituto de Investigación Sanitaria La Fe Valencia Spain; 9. Especialista en Medicina Interna/E. Infecciosas Hospital Universitario de La Princesa Madrid Spain; 10. HIV Unit. Internal Medicine Service Hospital Universitario Central de Asturias (HUCA) Oviedo University School of Medicine, Investigator, Microbiology and Infectious Diseases Group, ISPA‐FINBA Oviedo Spain; 11. Unidad de VIH‐UNITS Hospital Universitario Virgen de la Arrixaca Murcia Spain; 12. Servicio de Enfermedades Infecciosas, Hospital Universitario Reina Sofía Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO) Córdoba Spain; 13. Centro de Investigación Biomédica en Red (CIBER) ‐ Enfermedades Infecciosas (CIBERINFEC) Instituto de Salud Carlos III (ISCIII) Madrid Spain; 14. División de Enfermedades Infecciosas Hospital Universitario Fundación Jiménez Díaz. Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS‐FJD, UAM) Madrid Spain; 15. Servicio de Medicina Interna Hospital Universitari Son Espases Mallorca Spain; 16. Servicio de Enfermedades Infecciosas Hospital Universitario Donostia. IIS BioGipuzkoa. Departamento de Medicina; EHU‐Universidad del País Vasco San Sebastián Spain; 17. Fundación Rioja Salud CIBIR Logroño Spain; 18. Hospital Universitario de Canarias San Cristóbal de La Laguna Spain; 19. Department of Health Psychology University of Alicante Alicante Spain; 20. Alicante Institute for Health and Biomedical Research (ISABIAL) Alicante Spain; 21. Infectious Diseases Unit, Department of Internal Medicine Alicante University General Hospital Alicante Spain; 22. Hospital Universitari Joan XXIII de Tarragona Tarragona Spain; 23. Institut d'Investigacio Sanitaria Pere Virgili (IISPV) Tarragona Spain; 24. Centro de Investigación Biomedica en Red de Enfermedades Infecciosas (CIBERINFEC) Instituto de Salut Carlos III (ISCIII) Madrid Spain; 25. Universitat Rovira i Virgili (URV) Tarragona Spain; 26. Servicio de Medicina Interna, Hospital Universitario Infanta Sofía, FIIB HUIS HHEN San Sebastián de los Reyes Spain; 27. Department of Medicine. Faculty of Medicine, Health and Sports Universidad Europea de Madrid Madrid Spain; 28. Unidad de Enfermedades Infecciosas Hospital General Universitario De Elche & Universidad Miguel Hernández, Alicante. CIBERINFEC, Carlos III Health Institute Madrid Spain; 29. Unidad de Infecciosas de Medicina Interna del hospital Clínico San Carlos de Madrid. CIBERINFEC con código CB 21/1300126 Carlos III Health Institute Madrid Spain; 30. HIV and STI Unit, Department of Infectious Diseases Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona L'Hospitalet de Llobregat Spain; 31. Servicio de Medicina Interna Hospital Universitario Príncipe de Asturias Alcalá de Henares. Madrid. Conflictos de interés: I report personal fees from Gilead Sciences, ViiV, MSD and Janssen for developing educational presentations Alcalá de Henares Spain; 32. Unidad de Enfermedades Infecciosas Valencia Spain; 33. Hospital Universitario y Politécnico La Fe Valencia Spain; 34. Instituto de Investigación Sanitaria – IIS La FE Universidad de Valencia Valencia Spain; 35. CoRIS coordination unit Carlos III Health Institute and CIBERINFEC, Carlos III Health Institute Madrid Spain展开收起
124
天
Renal function in African women receiving tenofovir disoproxil fumarate as pre‐exposure prophylaxis for HIV during pregnancy and postpartum: A postpartum safety analysis in the CAP016 randomized control trial
作者
Gaysheen Kistan; Tonya Esterhuizen; Megeshinee Naidoo; Alicia C. Desmond; Motshedisi Sebitloane; Dhayendre Moodley展开收起
作者单位
1. Department of Obstetrics and Gynaecology, School of Clinical Medicine University of KwaZulu Natal Durban South Africa; 2. Division of Epidemiology and Biostatistics, Department of Global Health Stellenbosch University Tygerberg South Africa; 3. Centre for the Program of AIDS Research in South Africa (CAPRISA) Durban South Africa展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天